Epcoritamab + R-CHOP in patients with previously untreated (1L) high-risk diffuse large B-cell lymphoma, including double-hit/triple-hit lymphoma: Updated EPCORE NHL-2 data Meeting Abstract
| Authors: | Falchi, L.; Clausen, M. R.; Offner, F.; de Vos, S.; Brody, J.; Linton, K. M.; Snauwaert, S.; Cordoba, R.; Wu, J.; Bykhovski, I.; Rana, A.; Belada, D. |
| Abstract Title: | Epcoritamab + R-CHOP in patients with previously untreated (1L) high-risk diffuse large B-cell lymphoma, including double-hit/triple-hit lymphoma: Updated EPCORE NHL-2 data |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | hematologic malignancy; phase ii; diffuse large b-cell lymphoma; non-hodgkin lymphoma; bispecific; abcl |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S431 |
| End Page: | S432 |
| Language: | English |
| ACCESSION: | WOS:001062479600452 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01319-8 |
| Notes: | Meeting Abstract: ABCL-429 -- Source: Wos |
